2020 Abstracts

Download the 2020 Abstract List

Featured Abstracts, Virtual Symposium 2020 

Each year, NANETS selects up to 12 abstracts for oral presentation at the annual Multidisciplinary NET Medical Symposium. This year, NANETS is pleased to showcase the highest scoring abstracts among 100 submissions. A promising indication for the NET field is that 5 of the 8 selected Basic Science and Clinical abstracts are presented by researchers within their first five years of initial faculty appointment.  

The 12 featured abstracts for 2020 are listed below. Click the titles to view or download. All abstracts are available in the searchable NET Abstracts Library. Click a year to the left to open the library.

Young Investigators

Basic Science

• Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling, Catherine Tran, MD, University of Iowa
• Functional Genetic Screen to Identify Drivers of Pancreatic Neuroendocrine Tumor Pathogenesis, Chandra Kumar Maharjan, BS, The University of Iowa

Clinical Research

• Cross-Sectional Study Assessing the Feasibility of Using NET VITALS Communication Tool Among Patients with Neuroendocrine Tumors, Daneng Li, MD, City of Hope
• A Single-Centre Pilot Study for Radiosensitization of Everolimus with External Beam Radiotherapy for the Treatment of Metastatic Neuroendocrine Liver Metastasis, Sten Myrehaug, MD, Odette Cancer Centre  

Basic/Translational Science Oral Abstract Presentations

• Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms, Kevin Yang, BS, BC Cancer
• Efficacy of combined MEK and CDK targeted therapies for pancreatic neuroendocrine tumors, Ume Salma Shaik Amjad, PhD, University of Iowa
• The lineage transcription factors ASCL1, NKX2-1, and PROX1 form a regulatory network and control the expression of the ion channel, SCN3A, in small cell lung cancer, Karine Pozo, PhD, UT Southwestern Medical Center
• A Systematic Workflow to Identify Anti-cancer Drugs Targeting Small Bowel Neuroendocrine Tumors and Neuroendocrine Carcinomas, Po Hien Ear, PhD, University of Iowa

Clinical Research Oral Abstract Presentations

• Preliminary Safety, PK/PD, and Antitumor Activity of XmAb18087, an SSTR2 x CD3 Bispecific Antibody, in Patients with Advanced Neuroendocrine Tumors, Bassel El-Rayes, MD, Winship Cancer Institute at Emory University
• Retrospective Analysis of DIPNECH and Carcinoid Tumorlets Progressing to Invasive Pulmonary Carcinoid Tumors, Thomas Yang Sun, MD, Stanford School of Medicine
• 212Pb-AlphaMedixTM Targeted Alpha Therapy (TAT): A Potential Breakthrough in Treatment of Metastatic SSTR Expressing NET, Ebrahim Delpassand, MD, RadioMedix
• Upfront Small Bowel Resection for Small Bowel Neuroendocrine Tumors With Synchronous Metastases: A Propensity Matched Comparative Population-Based Analysis, Sean Bennett, MD, University of Toronto 

To view all abstracts, click on a year to the left to open the searchable NET Abstracts Library.

The Abstract Process

NANETS is committed to furthering neuroendocrine tumor disease diagnosis, treatment and management through research and education. With over 15,000 new patients diagnosed with NETs each year, there is a continuing need to support NET research and advance the dissemination of vital research findings. NANETS' Multidisciplinary NET Medical Virtual Symposium represents an excellent opportunity to present research relevant to cutting edge topics in neuroendocrine tumor research. Medical researchers at institutions in North America and around the world are invited to submit abstracts for presentation. NANETS encourages abstract reporting on recent NET research and/or describing ongoing or current clinical trials with the intent of increasing awareness of these studies.

Investigators may submit abstracts that have been presented at other scientific meetings and/or published in scientific journals since October 1 of the prior year. Abstracts are reviewed and scored by NANETS’ Scientific Review & Research Committee of NET medical research experts, and selected to be shown in poster sessions or as oral abstract presentations at the NANETS Annual Multidisciplinary NET Medical Symposium, held each fall. Ten to twelve oral abstracts will be selected for presentation in two education sessions at Symposium.  

Categories for submission are:

1. 1. Basic Science
   2. Applied Basic Science
   3. Chemo/SSA/Biologics (Clinical)
   4. Nuclear Medicine/Interventional Radiology/Imaging (Clinical)
   5. Surgical/Applied Pathology (Clinical)
   6. Population Science
   7.  Other
   8. Trials in Progress

Case reports are not accepted.

Abstracts are published in a comprehensive guide featuring the latest in NET research, archived on NANETS' website, as well as a large number being published in the medical journal Pancreas.

The submission period opens in early spring.